Dexcel Pharma
FDA Approved Drugs

Dexcel Pharma

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Discontinued OTC
  • Total Records 16
  • Latest Approval Date Apr 02, 2026
  • Data Source FDA
  • First Approval Date May 15, 1998
All
16
View
Discontinued
3
View
OTC
4
View
RX
9
View
Company Overview

Company

Dexcel Pharma

Country

Israel

Website

Visit Website

Email

info@dexcel.com

Social Profiles

Company Snapshot

Dexcel Pharma

1 Dexcel St., Or Akiva, 3060000

Israel

dexcel.com/ info@dexcel.com View on Map
FDA Approved Drug Records ( 16 records )
2016
19 Feb
RX Application: 203713

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

23MG

Approval Date

2016-02-19

203713 / 1

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

203713

Product Number

1

Dosage Form

-

Strength

23MG

Approval Date

2016-02-19

Regulatory Status

RX

2020
20 Oct
Discontinued Application: 214278

Drug Name

ESOMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2020-10-20

214278 / 1

Active Ingredient

ESOMEPRAZOLE MAGNESIUM

Application Number

214278

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2020-10-20

Regulatory Status

Discontinued

2019
03 Oct
RX Application: 211379

Drug Name

HEMADY

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2019-10-03

211379 / 1

Active Ingredient

DEXAMETHASONE

Application Number

211379

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2019-10-03

Regulatory Status

RX

2016
07 Jun
OTC Application: 208025

Drug Name

LANSOPRAZOLE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2016-06-07

208025 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

208025

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2016-06-07

Regulatory Status

OTC

2026
02 Apr
RX Application: 219819

Drug Name

NINTEDANIB ESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-04-02

219819 / 1

Active Ingredient

NINTEDANIB ESYLATE

Application Number

219819

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-04-02

Regulatory Status

RX

2026
02 Apr
RX Application: 219819

Drug Name

NINTEDANIB ESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2026-04-02

219819 / 2

Active Ingredient

NINTEDANIB ESYLATE

Application Number

219819

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2026-04-02

Regulatory Status

RX

2007
04 Dec
OTC Application: 22032

Drug Name

OMEPRAZOLE

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2007-12-04

22032 / 1

Active Ingredient

OMEPRAZOLE

Application Number

22032

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2007-12-04

Regulatory Status

OTC

2017
05 Jul
OTC Application: 209400

Drug Name

OMEPRAZOLE

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2017-07-05

209400 / 1

Active Ingredient

OMEPRAZOLE

Application Number

209400

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2017-07-05

Regulatory Status

OTC

2022
24 May
OTC Application: 216096

Drug Name

OMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2022-05-24

216096 / 1

Active Ingredient

OMEPRAZOLE MAGNESIUM

Application Number

216096

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2022-05-24

Regulatory Status

OTC

2023
16 Jun
RX Application: 216247

Drug Name

PANTOPRAZOLE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2023-06-16

216247 / 1

Active Ingredient

PANTOPRAZOLE SODIUM

Application Number

216247

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2023-06-16

Regulatory Status

RX

1998
15 May
Discontinued Application: 20774

Drug Name

PERIOCHIP

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

1998-05-15

20774 / 1

Active Ingredient

CHLORHEXIDINE GLUCONATE

Application Number

20774

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

1998-05-15

Regulatory Status

Discontinued

2024
16 Dec
RX Application: 218668

Drug Name

TOFACITINIB CITRATE

Product Number

1

Dosage Form

-

Strength

EQ 11MG BASE

Approval Date

2024-12-16

218668 / 1

Active Ingredient

TOFACITINIB CITRATE

Application Number

218668

Product Number

1

Dosage Form

-

Strength

EQ 11MG BASE

Approval Date

2024-12-16

Regulatory Status

RX

2019
31 Oct
RX Application: 209193

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2019-10-31

209193 / 1

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

209193

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2019-10-31

Regulatory Status

RX

2019
31 Oct
RX Application: 209193

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 225MG BASE

Approval Date

2019-10-31

209193 / 2

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

209193

Product Number

2

Dosage Form

-

Strength

EQ 225MG BASE

Approval Date

2019-10-31

Regulatory Status

RX

2021
13 May
Discontinued Application: 214992

Drug Name

VIGABATRIN

Product Number

1

Dosage Form

-

Strength

500MG/PACKET

Approval Date

2021-05-13

214992 / 1

Active Ingredient

VIGABATRIN

Application Number

214992

Product Number

1

Dosage Form

-

Strength

500MG/PACKET

Approval Date

2021-05-13

Regulatory Status

Discontinued

2021
23 Sep
RX Application: 215109

Drug Name

VIGABATRIN

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2021-09-23

215109 / 1

Active Ingredient

VIGABATRIN

Application Number

215109

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2021-09-23

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    16 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
16 total
  • RX
  • Discontinued
  • OTC
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

DONEPEZIL HYDROCHLORIDE

Application Number

203713

Product Number

1

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Dosage Form

-

Strength

23MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit